MENU
+Compare
SIBN
Stock ticker: NASDAQ
AS OF
Apr 4 closing price
Price
$13.47
Change
-$0.13 (-0.96%)
Capitalization
672.23M

SIBN SI-BONE Forecast, Technical & Fundamental Analysis

SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally... Show more

SIBN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for SIBN with price predictions
Apr 04, 2025

SIBN's RSI Oscillator stays in oversold zone for 1 day

It is expected that a price bounce should occur soon.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 22 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SIBN advanced for three days, in of 293 cases, the price rose further within the following month. The odds of a continued upward trend are .

SIBN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 04, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on SIBN as a result. In of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for SIBN turned negative on February 27, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at .

SIBN moved below its 50-day moving average on March 07, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for SIBN crossed bearishly below the 50-day moving average on March 13, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SIBN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for SIBN entered a downward trend on April 04, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.828) is normal, around the industry mean (23.715). P/E Ratio (0.000) is within average values for comparable stocks, (83.458). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (4.369) is also within normal values, averaging (41.612).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. SIBN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SIBN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
SIBN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

SIBN is expected to report earnings to rise 105.09% to -22 cents per share on May 12

SI-BONE SIBN Stock Earnings Reports
Q1'25
Est.
$-0.23
Q4'24
Beat
by $0.04
Q3'24
Beat
by $0.08
Q2'24
Beat
by $0.06
Q1'24
Beat
by $0.04
The last earnings report on February 24 showed earnings per share of -10 cents, beating the estimate of -15 cents. With 402.26K shares outstanding, the current market capitalization sits at 672.23M.
A.I. Advisor
published General Information

General Information

a sacroiliac joint medical device company

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
471 El Camino Real
Phone
+1 408 207-0700
Employees
344
Web
https://www.si-bone.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EQPIX35.270.16
+0.44%
Fidelity Advisor Equity Income I
BBTGX29.67N/A
N/A
Sterling Capital Behav Lg Cp Val Eq A
FCPCX25.20N/A
N/A
Fidelity Advisor Intl Cap App C
TLGAX11.58N/A
N/A
Timothy Plan Large/Mid Cap Growth A
VGORX48.77N/A
N/A
Voya Large-Cap Growth R

SIBN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SIBN has been loosely correlated with QTRX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if SIBN jumps, then QTRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SIBN
1D Price
Change %
SIBN100%
-0.96%
QTRX - SIBN
44%
Loosely correlated
-4.35%
AORT - SIBN
42%
Loosely correlated
-3.81%
LAB - SIBN
41%
Loosely correlated
N/A
NVRO - SIBN
41%
Loosely correlated
N/A
KIDS - SIBN
38%
Loosely correlated
-3.90%
More